Healing Touch Osteopathic Pc General Practice Medicare: Not Enrolled in Medicare Practice Location: 10199 W Carlton Bay Dr, Garden City, ID 83714 Phone: 208-488-8408 |
Sterling Provider Group Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 6965 N Glenwood St, Garden City, ID 83714 Phone: 208-853-3000 Fax: 208-542-9114 |
Cottonwood Family Medicine Pllc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5999 W State St Ste B, Garden City, ID 83703 Phone: 208-995-2875 Fax: 208-995-2874 |
Primary Health Medical Group Family Medicine Medicare: Medicare Enrolled Practice Location: 10482 W Carlton Bay Dr, Garden City, ID 83714 Phone: 208-955-6500 Fax: 208-955-6503 |
Afc Urgent Care Clinic/Center - Multi-Specialty Medicare: Medicare Enrolled Practice Location: 6965 N Glenwood St, Garden City, ID 83714 Phone: 208-853-3000 |
Primary Health Medical Group Family Medicine Medicare: Medicare Enrolled Practice Location: 5601 W. Chinden Blvd., Garden City, ID 83714 Phone: 208-809-2865 Fax: 208-809-2866 |
News Archive
Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging(MRI) to determine the health of a patient, can be improved, according to Rice University engineers who are refining models they first used to enhance oil and gas recovery.
The National Multiple Sclerosis Society has committed $28 million to support an expected 84 new MS research projects and training awards. These are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the disease forever – for every single person with MS.
Type 1 diabetes is the autoimmune form of diabetes, in which the patients' insulin-producing beta cells are destroyed by their own immune system. "We know that if a person has two autoantibodies and one of them is against insulin, there is a 50 per cent risk that they will develop type 1 diabetes within five years. It doesn't matter how old you are", says Ake Lernmark, Professor of Experimental Diabetes Research at Lund University in Sweden.
A Queen's University study of fruit flies that may revolutionize the way birth defects are studied has identified the genes affected by a widely-prescribed drug known to cause birth defects.
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that its investigational new drug application (IND 109196) for its novel drug mibefradil has been accepted by the Food and Drug Administration (FDA).
› Verified 1 days ago